What Researchers Did
Researchers tested whether adding hyperbaric oxygen therapy to the antidepressant escitalopram oxalate changed outcomes in 118 randomly divided patients with depression after a stroke, and they also tested a computer method for cleaning up MRI images.
What They Found
In a randomized study of 118 patients with poststroke depression, the group given hyperbaric oxygen therapy plus escitalopram oxalate had lower stroke severity (NIHSS) and depression (HAMD) scores after treatment than the group given escitalopram oxalate alone. The abstract reports a sleep score (PSQI) that was higher in the hyperbaric group, and it describes this as improved sleep quality. Blood levels of GFAP, a brain-injury marker, were lower in the hyperbaric group (852.46 versus 948.53), while norepinephrine was higher (1478.59 versus 1061.80). The abstract states all these comparisons were statistically significant (p less than 0.05). For the imaging part, the low-rank matrix method had a higher error value than the nonlocal mean method (92.39 versus 80.54) and a lower image quality value (25.35 versus 29.07).
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract does not report the hyperbaric protocol, the follow-up length, or whether patients and staff were blinded, and the image-processing results were weaker than the comparison method on both measures the abstract reports.